Skip to main content

Table 5 Characteristics of studies included in comparable meta-analysis reporting PSM rate

From: Oncological safety of intrafascial nerve-sparing radical prostatectomy compared with conventional process: a pooled review and meta-regression analysis based on available studies

First author Selection balance Criteria for Intra-RP Criteria for Inter-RP SSOS for Intra-RP Percent of pT2 cancer, % (Intra-RP vs Inter-RP) PSM rate, % (Intra-RP vs Inter-RP)
pT2 pT3 all-stage
VIP 2005 N cT1c and PSA ≤ 10 and Gleason score ≤ 6 cT2a/b or PSA > 10 ≤ 20 or Gleason score = 7 11     2.2: 3.3
Zheng 2013 N cT1/2a and PSA ≤ 10 and Gleason score ≤ 3 + 4 and positive cores≤3/12 cT2b/c or positive cores > 3/12 and PSA ≤ 10 and Gleason score ≤ 3 + 4 12     12.3: 16.2
Khoder 2014 N cT1/2 and PSA ≤ 10 and Gleason score ≤ 6 cT1/2 and PSA ≤ 15 and Gleason score ≤ 7 8 92.3: 81.9 8.8: 18.1 72.2: 51.5 13.7: 24.2
Potdevin 2009 Y cT1/2a and PSA ≤ 10 and Gleason score ≤ 7 8 75.7: 88.3 7.5: 5.9 41.2: 22.2 15.7: 7.8
Neil 2009 Y cT1/2 and PSA ≤ 10 and absence of primary Gleason pattern 4/5 7     11.7: 11.1
Stolzenburg 2010 Y cT1/2a and PSA < 10 and Gleason score ≤ 3 + 4 9 89: 81 6.2: 5.6 31.8: 26.3 9.0: 9.5
  1. Intra-RP intrafascial radical prostatectomy, Inter-RP interfascial radical prostatectomy, SSOS Selection Score of Oncologic Safety, VIP Vattikuti Institute Prostatectomy, Y yes, N no.